Atlas Trials

European Stop Tyrosine Kinase Inhibitor Study

Clinical trial NCT01596114 · COMPLETED

Trial details

NCT number
NCT01596114
Sponsor
European LeukemiaNet
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia
Start date
2012-05-30
Primary completion
2014-12-03
Enrollment
868

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.